Medicare Part D Patients Paying More For Generics
Over Half Of Generic Drugs Are Not On Medicare Part D Generic Tiers This Year, Avelere Finds
The latest AAM-sponsored study from Avalere Health has found that, for the third year in the row, an increasing percentage of generic drugs are being placed on higher-cost non-generic tiers, even as the overall price of generic drugs decreases.
